v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (123,919,189) $ (117,274,218)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation 4,063,175 1,945,212
Change in fair value of convertible notes and warranty liability, and loss on conversion to common stock 8,285,425 1,769,857
Deferred revenue (180,000) 500,000
Gain on sale of property, plant & equipment 0 379,406
Stock-based compensation 13,422,135 11,460,211
Impairment of investment in Tropos 10,000,000 0
Reserve of inventory and prepaid purchases 8,798,690 17,716,995
Non-cash lease expense 1,506,310 1,092,473
Other non-cash items (1,934,310) 599,982
Effects of changes in operating assets and liabilities:    
Accounts receivable (349,512) (16,929,567)
Inventory (39,294,091) (16,629,172)
Prepaid expenses and other current assets (890,626) (9,665,250)
Other assets 0 (84,401)
Accounts payable and accrued liabilities (2,227,029) 33,676,050
Warranty liability (305,027) (2,376,242)
Net cash used in operating activities (123,024,049) (93,818,664)
Cash flows from investing activities:    
Capital expenditures (18,687,451) (17,496,795)
Investment in Tropos 0 (5,000,000)
Proceeds from sale of property, plant & equipment 0 2,477,276
Net cash used in investing activities (18,687,451) (20,019,519)
Cash flows from financing activities:    
Proceeds from issuance of convertible notes 17,500,000 0
Proceeds from issuance of common stock 62,155,939 12,884,243
Exercise of warrants and options and restricted share award activity (495,381) (559,637)
Payments on finance lease (879,444) (857,516)
Net cash provided by financing activities 78,281,114 11,467,090
Change in cash, cash equivalents and restricted cash (63,430,386) (102,371,093)
Cash, cash equivalents and restricted cash, beginning of the year 99,276,301 201,647,394
Cash, cash equivalents and restricted cash, end of the year $ 35,845,915 $ 99,276,301

Source